MicroPort CardioFlow Medtech Corporation (FRA:72X)

FRA:72X Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	332.07	108.03	1,065	1,866	2,212	612.47
Short-Term Investments	989.17	1,252	710.61	212.74	206.41	9.25
Cash & Short-Term Investments	1,321	1,360	1,776	2,079	2,418	621.72
Cash Growth	-15.41%	-23.41%	-14.59%	-14.02%	288.92%	451.91%
Accounts Receivable	241.63	155.77	101	49.78	74.71	4.66
Other Receivables	24.19	15.22	31.53	4.65	24.07	25.49
Receivables	265.82	170.99	132.53	54.43	98.78	30.16
Inventory	108.75	135.38	122.87	114.12	82.73	67.77
Other Current Assets	7.96	8.06	10.24	24.17	0.33	0.33
Total Current Assets	1,704	1,674	2,041	2,272	2,600	719.97
Property, Plant & Equipment	479.33	505.96	196.97	241.72	267.17	68.12
Long-Term Investments	262.37	258.38	167.37	298.17	231.01	83.52
Other Intangible Assets	177.64	1.91	3.43	2.18	0.51	0.48
Long-Term Deferred Charges	-	190.38	140.46	160.94	238.24	233.69
Other Long-Term Assets	44.4	44.66	27.55	26.49	25.27	6.41
Total Assets	2,668	2,676	2,577	3,001	3,362	1,112
Accounts Payable	28.13	39.79	53.25	47.69	54.92	15.54
Accrued Expenses	30.22	28.92	37.67	28.43	20.12	15.07
Current Portion of Long-Term Debt	60.45	37.5	-	-	-	-
Current Portion of Leases	19.32	25.58	28.57	31.04	34.7	7.2
Current Income Taxes Payable	8.37	6.94	7.21	1.77	-	-
Current Unearned Revenue	12.83	5.31	4.94	6.09	2.96	-
Other Current Liabilities	86.21	289.85	61.95	62.21	51.74	1,394
Total Current Liabilities	245.53	433.89	193.58	177.23	164.43	1,432
Long-Term Debt	194.58	4	-	-	-	-
Long-Term Leases	5.27	9.78	41.91	64.43	90.94	8.63
Long-Term Unearned Revenue	5.17	6.4	6.75	5.89	2.25	3.39
Other Long-Term Liabilities	-	-	-	-	7.9	13.66
Total Liabilities	450.55	454.07	242.25	247.55	265.52	1,457
Common Stock	0.08	0.08	0.08	0.08	0.08	0.04
Additional Paid-In Capital	4,172	4,172	4,171	4,164	4,151	481.84
Retained Earnings	-1,793	-1,795	-1,748	-1,279	-824.68	-641.8
Comprehensive Income & Other	-196.02	-189.93	-88.22	-131.74	-229.87	-185.28
Total Common Equity	2,183	2,187	2,335	2,754	3,096	-345.2
Minority Interest	34.45	34.48	-	-	-	-
Shareholders' Equity	2,217	2,222	2,335	2,754	3,096	-345.18
Total Liabilities & Equity	2,668	2,676	2,577	3,001	3,362	1,112
Total Debt	279.62	76.86	70.48	95.47	125.64	15.83
Net Cash (Debt)	1,042	1,283	1,705	1,984	2,292	605.89
Net Cash Growth	-29.28%	-24.75%	-14.03%	-13.47%	278.34%	739.81%
Net Cash Per Share	0.45	0.55	0.72	0.84	0.98	0.35
Filing Date Shares Outstanding	2,413	2,413	2,412	2,409	2,404	1,212
Total Common Shares Outstanding	2,413	2,413	2,412	2,409	2,404	1,212
Working Capital	1,458	1,241	1,848	2,095	2,435	-711.73
Book Value Per Share	0.90	0.91	0.97	1.14	1.29	-0.28
Tangible Book Value	2,005	2,185	2,331	2,752	3,096	-345.68
Tangible Book Value Per Share	0.83	0.91	0.97	1.14	1.29	-0.29
Machinery	-	107.28	96.38	85.77	55.12	26.88
Construction In Progress	-	0.52	3.38	6.14	73.54	25.63
Leasehold Improvements	-	87.88	79.62	86.57	23.91	10.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.